These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18772348)

  • 1. Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?
    Jadin L; Wu X; Ding H; Frost GI; Onclinx C; Triggs-Raine B; Flamion B
    FASEB J; 2008 Dec; 22(12):4316-26. PubMed ID: 18772348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis.
    Martin DC; Atmuri V; Hemming RJ; Farley J; Mort JS; Byers S; Hombach-Klonisch S; Csoka AB; Stern R; Triggs-Raine BL
    Hum Mol Genet; 2008 Jul; 17(13):1904-15. PubMed ID: 18344557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation.
    Atmuri V; Martin DC; Hemming R; Gutsol A; Byers S; Sahebjam S; Thliveris JA; Mort JS; Carmona E; Anderson JE; Dakshinamurti S; Triggs-Raine B
    Matrix Biol; 2008 Oct; 27(8):653-60. PubMed ID: 18762256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronidase 1 and hyaluronidase 2 are required for renal hyaluronan turnover.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Flamion B; Caron N
    Acta Histochem; 2015 Jan; 117(1):83-91. PubMed ID: 25468725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.
    Triggs-Raine B; Salo TJ; Zhang H; Wicklow BA; Natowicz MR
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6296-300. PubMed ID: 10339581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respective roles of hyaluronidases 1 and 2 in endogenous hyaluronan turnover.
    Bourguignon V; Flamion B
    FASEB J; 2016 Jun; 30(6):2108-14. PubMed ID: 26887442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure.
    Chowdhury B; Xiang B; Liu M; Hemming R; Dolinsky VW; Triggs-Raine B
    Circ Cardiovasc Genet; 2017 Jan; 10(1):e001598. PubMed ID: 28196902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of hyaluronidases exacerbates renal post-ischemic injury, inflammation, and fibrosis.
    Colombaro V; Jadot I; Declèves AE; Voisin V; Giordano L; Habsch I; Malaisse J; Flamion B; Caron N
    Kidney Int; 2015 Jul; 88(1):61-71. PubMed ID: 25715119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction.
    Chowdhury B; Hemming R; Hombach-Klonisch S; Flamion B; Triggs-Raine B
    J Biol Chem; 2013 Jan; 288(1):520-8. PubMed ID: 23172227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells.
    Hemming R; Martin DC; Slominski E; Nagy JI; Halayko AJ; Pind S; Triggs-Raine B
    Glycobiology; 2008 Apr; 18(4):280-9. PubMed ID: 18234732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronidase 2 (HYAL2) is expressed in endothelial cells, as well as some specialized epithelial cells, and is required for normal hyaluronan catabolism.
    Chowdhury B; Hemming R; Faiyaz S; Triggs-Raine B
    Histochem Cell Biol; 2016 Jan; 145(1):53-66. PubMed ID: 26515055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.
    Bertrand P; Courel MN; Maingonnat C; Jardin F; Tilly H; Bastard C
    Int J Cancer; 2005 Jan; 113(2):207-12. PubMed ID: 15386412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.
    Onclinx C; Dogne S; Jadin L; Andris F; Grandfils C; Jouret F; Mullier F; Flamion B
    Haematologica; 2015 Aug; 100(8):1023-30. PubMed ID: 25934767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of hyaluronan and hyaluronidase 2 (HYAL2) in breast cancer.
    Fujisawa S; Takagi K; Yamaguchi-Tanaka M; Sato A; Miki Y; Miyashita M; Tada H; Ishida T; Suzuki T
    Pathol Res Pract; 2024 Aug; 260():155434. PubMed ID: 38991455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronidase 1 deficiency decreases bone mineral density in mice.
    Puissant E; Gilis F; Tevel V; Vandeweerd JM; Flamion B; Jadot M; Boonen M
    Sci Rep; 2022 Jun; 12(1):10142. PubMed ID: 35710820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmented hyaluronan is an autocrine chemokinetic motility factor supported by the HAS2-HYAL2/CD44 system on the plasma membrane.
    Saito T; Kawana H; Azuma K; Toyoda A; Fujita H; Kitagawa M; Harigaya K
    Int J Oncol; 2011 Nov; 39(5):1311-20. PubMed ID: 21743962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of hyaluronan catabolism in chondrocytes by mechanical stimuli.
    Tanimoto K; Kitamura R; Tanne Y; Kamiya T; Kunimatsu R; Yoshioka M; Tanaka N; Tanaka E; Tanne K
    J Biomed Mater Res A; 2010 Apr; 93(1):373-80. PubMed ID: 19569218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase.
    Andre B; Duterme C; Van Moer K; Mertens-Strijthagen J; Jadot M; Flamion B
    Biochem Biophys Res Commun; 2011 Jul; 411(1):175-9. PubMed ID: 21740893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism.
    Triggs-Raine B; Natowicz MR
    World J Biol Chem; 2015 Aug; 6(3):110-20. PubMed ID: 26322170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions.
    Duterme C; Mertens-Strijthagen J; Tammi M; Flamion B
    J Biol Chem; 2009 Nov; 284(48):33495-508. PubMed ID: 19783662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.